Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Day

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
Hepatology (Baltimore, Md.)|August 30, 2012
Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver diseaseSudeep Tanwar, Paul M Trembling, Indra N Guha, et al.
BMC Cancer|August 7, 2009
A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver diseaseJoe Gray, Dipankar Chattopadhyay, Gary S Beale, et al.
Journal of Hepatology|July 16, 2011
The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studiesAhmad Al-Serri, Quentin M Anstee, Luca Valenti, et al.
Gut|March 23, 2016
Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver diseaseTimothy Hardy, Mujdat Zeybel, Christopher P Day, et al.
Nature Reviews. Disease Primers|May 19, 2016
Nonalcoholic fatty liver diseaseElizabeth M Brunt, Vincent W-S Wong, Valerio Nobili, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 15, 2017
Effects of Exercise on Liver Fat and Metabolism in Alcohol DrinkersDavid Houghton, Kate Hallsworth, Christian Thoma, et al.
Hepatology (Baltimore, Md.)|November 27, 2007
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markersIndra Neil Guha, Julie Parkes, Paul Roderick, et al.
Hepatology (Baltimore, Md.)|June 21, 2011
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative studyNeeraj Bhala, Paul Angulo, David van der Poorten, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 14, 2016
Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled TrialDavid Houghton, Christian Thoma, Kate Hallsworth, et al.
Journal of Hepatology|July 23, 2011
The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liverLuca Valenti, Valerio Nobili, Ahmad Al-Serri, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Hepatology (Baltimore, Md.)|August 30, 2012
Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver diseaseSudeep Tanwar, Paul M Trembling, Indra N Guha, et al.
BMC Cancer|August 7, 2009
A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver diseaseJoe Gray, Dipankar Chattopadhyay, Gary S Beale, et al.
Journal of Hepatology|July 16, 2011
The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studiesAhmad Al-Serri, Quentin M Anstee, Luca Valenti, et al.
Gut|March 23, 2016
Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver diseaseTimothy Hardy, Mujdat Zeybel, Christopher P Day, et al.
Nature Reviews. Disease Primers|May 19, 2016
Nonalcoholic fatty liver diseaseElizabeth M Brunt, Vincent W-S Wong, Valerio Nobili, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 15, 2017
Effects of Exercise on Liver Fat and Metabolism in Alcohol DrinkersDavid Houghton, Kate Hallsworth, Christian Thoma, et al.
Hepatology (Baltimore, Md.)|November 27, 2007
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markersIndra Neil Guha, Julie Parkes, Paul Roderick, et al.
Hepatology (Baltimore, Md.)|June 21, 2011
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative studyNeeraj Bhala, Paul Angulo, David van der Poorten, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 14, 2016
Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled TrialDavid Houghton, Christian Thoma, Kate Hallsworth, et al.
Journal of Hepatology|July 23, 2011
The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liverLuca Valenti, Valerio Nobili, Ahmad Al-Serri, et al.
Pageof 13